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ABSTRACT
Synthetic genetic sensors and circuits enable pro-
grammable control over the timing and conditions of
gene expression. They are being increasingly
incorporated into the control of complex, multigene
pathways and cellular functions. Here, we propose a
design strategy to genetically separate the sensing/
circuitry functions from the pathway to be
controlled. This separation is achieved by having
the output of the circuit drive the expression of a
polymerase, which then activates the pathway
from polymerase-specific promoters. The sensors,
circuits and polymerase are encoded together on a
‘controller’ plasmid. Variants of T7 RNA polymerase
that reduce toxicity were constructed and used as
scaffolds for the construction of four orthogonal
polymerases identified via part mining that bind to
unique promoter sequences. This set is highly or-
thogonal and induces cognate promoters by 8- to
75-fold more than off-target promoters. These or-
thogonal polymerases enable four independent
channels linking the outputs of circuits to the
control of different cellular functions. As a demon-
stration, we constructed a controller plasmid that
integrates two inducible systems, implements an
AND logic operation and toggles between metabolic
pathways that change Escherichia coli green
(deoxychromoviridans) and red (lycopene). The ad-
vantages of this organization are that (i) the regula-
tion of the pathway can be changed simply by
introducing a different controller plasmid, (ii) tran-
scription is orthogonal to host machinery and
(iii) the pathway genes are not transcribed in the
absence of a controller and are thus more easily
carried without invoking evolutionary pressure.
INTRODUCTION
Synthetic genetic circuits have been constructed by engin-
eering biochemical interactions to generate signal process-
ing or dynamic functions (e.g. a logic gate or oscillator)
(1–4). These circuits can be connected to each other to
implement more intricate computational operations
(5,6). Further, genetic sensors, which respond to environ-
mental stimuli, can be connected as inputs to the circuits
(7,8). The outputs can be used to control actuators that
determine what the cell is making or doing. A number of
‘toy systems’ have been constructed to develop the design
principles by which multiple sensors, circuits and actu-
ators can be combined into larger programs. Such
programs link cell–cell communication for bioﬁlm forma-
tion, enable Escherichia coli to form patterns, and control
the direction of chemotaxis (9–12). For practical applica-
tions, simple circuits have been used to control metabolic
pathways to implement feedback or to turn on at a par-
ticular growth phase (13–15). Increasingly sophisticated
programs containing many sensors and circuits will be
required to integrate multiple cellular processes, imple-
ment ﬁne spatial and temporal control over gene expres-
sion and move process control algorithms into individual
cells. As the programs become larger, it will be more
challenging to design and test in isolation before moving
to control relevant pathways. Here, we present a design
strategy that relies on multiple engineered phage polymer-
ases to link the output of genetic programs with the
pathways to be controlled, both of which are carried in
distinct genetic locations. This modular design allows the
program and pathways to be constructed and tested inde-
pendently and then combined to create a complete oper-
ational system.
When introducing synthetic DNA into a cell, it is desir-
able that the encoded processes be functionally distinct
from host processes. This has been articulated as
building a ‘virtual machine’ in cells that make separate
transcription/translation machinery and resources
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available to a synthetic system, thus reducing the load on
the host (16). To this end, RNA regulator systems have
been engineered to produce orthogonal parts libraries for
controlling gene expression (17,18). Similarly, phage poly-
merases are a means to control orthogonal transcription
and are one of the most used tools in genetic engineering.
Speciﬁcally, T7 RNA polymerase (RNAP) has been
shown to function in a variety of hosts, including
Gram-negative and -positive bacteria, plant chloroplasts
and mammalian cells (19–21). An advantage of T7 poly-
merase is that its promoters are tightly inactive in the
absence of the polymerase, thus reducing the load on the
cell when uninduced (20,22). Recent advances in
manipulating and minimizing the ribosome and altering
the 16S rRNA to bind to alternative Shine-Delgarno
sites are important steps towards the ultimate goal of sim-
ultaneous orthogonal translation (23,24).
In this article, we present a design strategy to separate
sensing/circuitry functions from pathways/actuation
(Figure 1A). They are encoded in genetically distinct
regions and linked by having the output of the circuits
drive the expression of phage polymerases. This enables
the ‘controller’ to be optimized independently using ﬂuor-
escent proteins and then transferred to the control of a
pathway. Bioinformatics and protein engineering were
applied to build four orthogonal polymerases by
swapping the DNA-binding loop from homologues
mined from sequence databases. This yielded orthogonal
polymerases that do not cross-react with non-cognate pro-
moters and thus can be used to control four distinct
pathways or actuators. Promoter libraries for the poly-
merases were constructed to enable tuneable control
over the expression levels. Further, multiple terminators
were constructed to enable multicistron systems be
controlled by a polymerase without problems due to hom-
ologous recombination. Together, this approach de-
couples the design of a pathway from the regulation
used to control it.
MATERIALS AND METHODS
Strains and media
Escherichia coli strain DH10B was used for routine
cloning, plasmid propagation and T7 characterization
assays. E. coli strain MG1655 was used for pigment
expression. Luria–Bertani (LB)-Miller (Difco) was used
for strain propagation and assays. The antibiotics
used were 34.4 mg·ml1 chloramphenicol, 100mg·ml1
spectinomycin, 50 mg·ml1 kanamycin and/or
100 mg·ml1 ampicillin. The inducers used were isopropyl
b-D-1-thiogalactopyranoside (Sigma-Aldrich) and/or
anhydrotetracycline (Sigma-Aldrich).
Computational methods
RNAP homologues were identiﬁed using BLAST (http://
blast.ncbi.nlm.nih.gov/) (25). The search was run against
the non-redundant protein sequence database, with an
expect threshold of 10, word size of 3, the BLOSUM62
matrix, gap costs of 11 for existence and 1 for exten-
sion and the conditional compositional score matrix
adjustment. Protein sequences were aligned using
ClustalW (http://www.ebi.ac.uk/Tools/msa/clustalw2/)
(26). Pairwise alignment utilized the Gonnet weight
matrix, a gap opening penalty of 100 and an extension
penalty of 0.1. The multiple sequence alignment also
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Figure 1. Separation of synthetic regulation onto a genetic controller using orthogonal phage polymerases. (A) The controller contains genetic
sensors and circuits, the output of which is the expression of a phage RNAP, which then activates a pathway. The pathways can be programmed to
respond to different conditions by swapping the controller without further genetic manipulation. (B) Modiﬁcations are shown to reduce the toxicity
of T7 RNAP, the details of which are described in the text. (C) Toxicity of T7 RNAP variants is shown. Each variant was co-transformed with a
different plasmid bearing a T7 promoter, and cells were grown on plates containing 1 mM IPTG to fully induce RNAP expression from the Ptac
promoter. RNAP variants containing different combinations of modiﬁcations are shown (v1=T7 RNAP in pIncW plasmid, v2=addition of Lon
tag to v1, v3=addition of weak RBS and GTG start codon to v2). The data are shown for the expression of the T7 variant in the absence of a T7
promoter (black, plasmid N23, Supplementary Data) and the T7 promoter driving red ﬂuorescent protein (white, plasmid N155, Supplementary
Data). Asterisks indicate that no colonies were observed.
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utilized the Gonnet matrix, a gap opening penalty of 10,
an extension penalty of 0.2, gap distances of 5 and no end
gaps. Phage promoters were identiﬁed by scanning phage
genomes with the PHIRE package (http://www.biw
.kuleuven.be/logt/PHIRE.htm) (27). Default parameters
were used (string length 20, degeneracy 4, dominanNum
4 and window size 20).
Fluorescence characterization via ﬂow cytometry
Cells harbouring the appropriate plasmids were
inoculated into 5ml of LB media (supplemented with anti-
biotics, 37C, 250 rpm) in 15ml Falcon tubes and grown
for 14 h. The cultures were diluted into fresh 5ml LB
media (supplemented with antibiotics and inducers) to a
ﬁnal OD600 of 0.25 in 15ml Falcon tubes and were
incubated for 6 h (37C, 250 rpm). To halt the assay, 2 ml
of cells were transferred from each tube to a 96-well plate
containing phosphate-buffered saline supplemented with
2mg·ml1 kanamycin. Fluorescence data were collected
using a BD Biosciences LSRII ﬂow cytometer. GFP meas-
urements utilized a 488 nm laser with a 530/30 nm ﬁlter,
and mRFP measurements utilized a 532 nm laser with 575/
26 nm ﬁlter. Data were gated by forward and side scatter,
and each dataset consisted of at least 25 000 cells. FlowJo
was used to calculate the geometric means of the ﬂuores-
cence distributions and perform compensation. The
autoﬂuorescence value of E. coli cells harbouring no
plasmid was subtracted to generate the values reported
in this study.
RNAP toxicity assay
To assess RNAP toxicity, we measured the impact of
RNAP-mediated expression on cell viability. Cells were
co-transformed with an RNAP plasmid and one of the
three reporter plasmids. The reporter plasmids carried
no insert (N23), a wild-type T7 promoter with lacO-
binding site and mRFP that produces moderate gene
expression (N155) or a wild-type T7 promoter without
lacO-binding site and mRFP producing high levels of
gene expression (N489). Cells carrying appropriate
plasmids were grown as described for the assay to charac-
terize ﬂuorescence. After dilution to an OD600 of 0.25,
cells were further diluted by a factor of 106, and 50 ml of
cells were plated on LB media containing antibiotics and
100 mM IPTG. After 14 h of incubation at 37C, colonies
that had formed on each plate were counted.
Pigment production and quantiﬁcation
Strains were grown as in the Fluorescence
Characterization assay with an exception. Instead of incu-
bation in inducing media for 6 h, cells were grown 24 h
before pigment extraction and quantiﬁcation. After 24 h
of induction, cultures were diluted to an OD600 of 1.0, and
1ml of diluted culture was centrifuged at 15 000g for
60 sec. Supernatant was removed, cells were resuspended
in 200ml H2O, and re-centrifuged at 15 000g for 60 sec.
The pigments were then extracted from cell pellets follow-
ing one of the two methods. For lycopene extraction,
cells were resuspended in 250 ml acetone and incubated
at 55C for 15min with frequent vortexing. For
deoxychromoviridans extraction, after removal of super-
natant, cells were resuspended in 50 ml of 10% sodium
dodecyl sulfate and incubated at 55C for 15min with
frequent vortexing. Following, 250 ml of methanol were
added to the tubes. The mixture was incubated at 55C
for an additional 15min with frequent vortexing. Pigment
extraction mixtures (both lycopene and deoxychro-
moviridans) were then centrifuged at 15 000g for 60 sec
and the supernatant was transferred to a 96-well plate
for quantiﬁcation. Absorbance spectra from 350 to
700 nm were collected using a Tecan Saﬁre plate spectro-
photometer. Lycopene and deoxychromoviridans were
quantiﬁed using measurements at 470 and 650 nm, re-
spectively. Data are reported as the percent of max ab-
sorbance observed after subtraction of the absorbance of
wild-type E. coli MG1655 cell extracts.
Creation of synthetic parts
T7 promoters of varying strength were generated from a
random library and cloned in front of mRFP (28). The
promoter was randomized in the following way: TAATA
CGACTCACTANNNNNAGA. The library was screened
by picking 36 random colonies and growing overnight in
5ml LB media containing 1mM IPTG. Fluorescence was
measured by ﬂow cytometry, and four representative
clones that exhibited diverse strengths were selected for
further analysis. These four clones were sequenced and
characterized. T7 terminators were generated from a
random library and inserted into the characterization
vector N292 (SBa_000566). The T7 terminator library
was diversiﬁed as follows: TANNNAACCSSWWSSNSS
SSTCWWWCGSSSSSSWWSSGTTT. The terminator
library was co-transformed with T7* to screen for active
terminators. Thirty-six colonies were selected and grown
overnight in 5ml LB media containing 1mM IPTG.
Fluorescence was measured by ﬂow cytometry, and eight
clones that exhibited highest termination were selected for
further analysis. These eight clones were sequenced and
characterized. The RBS Calculator (‘Forward Engine-
ering’ mode, ‘ACCTCCTTA’ as the 16S RNA sequence)
was used to generate RBSs of 25 000 AU for each gene in
the lycopene biosynthetic pathway. Insulator sequences
were designed using the Random DNA Generator using
a random GC content of 50% (http://www.faculty.ucr
.edu/mmaduro/random.htm).
Part sequences are listed in Supplementary Table S1,
and plasmid maps are shown in Supplementary
Figure S10.
Engineering phage polymerases
Each orthogonal polymerase was constructed in the T7*
backbone. The speciﬁcity loop for the N4 subfamily was
inserted in T7*, and the gene was cloned into pIncW
without further modiﬁcation. This construct is denoted
T7*(N4). The K1F and T3 speciﬁcity loops were cloned
into T7*, combined with the Lon-mediated N-terminal
degradation tag (LFIKPADLREIVTFPLFSDLVQCGF
PSPAADYVEQRIDL) and inserted in pIncW to
produce T7*(K1F) and T7*(T3).
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RESULTS AND DISCUSSION
A practical challenge in using phage polymerases is that
they can exhibit toxicity (20,29,30). To overcome this, we
constructed a variant of T7 RNAP with reduced toxicity
by combining mutations to lower its concentration and
activity. The wild-type gene was placed under control of
an IPTG-inducible promoter in a low copy plasmid and
co-transformed with a second plasmid containing a T7
promoter and ﬂuorescent reporter (Figure 1B). Toxicity
was assessed by plating strains on inducing media and
counting colonies after 24 h of growth. Signiﬁcant
toxicity was observed when T7 RNAP is highly expressed,
even in the absence of a T7 promoter (Figure 1C, v1). A
Lon-mediated N-terminal degradation tag from the umuD
gene in E. coli (31) was added to limit polymerase concen-
tration (Figure 1C, v2). This resulted in a slightly lower
toxicity. Next, RNAP expression was tightly controlled
using a weak ribosome-binding site and GTG start
codon. Finally, during cloning, a spontaneous mutation
in the polymerase active site (R632S) arose. This mutation
was found to signiﬁcantly reduce host toxicity while main-
taining activity (Figure 1C, v3). It is interesting to note
that the previous studies have reported that mutations to
this region of the polymerase can reduce its processivity
(32–34).
Once the toxicity was reduced, we sought to expand the
number of polymerases that are orthogonal and can be
used simultaneously in a cell. In the context of a control-
ler, this would increase the number of circuit outputs that
could be linked to different pathways (Figure 1A).
Orthogonality can be achieved by engineering polymer-
ases to bind to different promoters and not cross-react.
One approach would be to apply part mining (35),
where homologous phage polymerases are identiﬁed
from the sequence databases, constructed using DNA
synthesis and screened for activity and orthogonality.
However, we did not want to repeat the process of
reducing the toxicity for each polymerase. To avoid this,
we used the set of T7 backbones (v1 to v3) as scaffolds
into which we inserted the peptide loop responsible for
promoter recognition from different phage polymerases
identiﬁed in the NCBI database (Figure 2A). These
chimeras were then tested for activity and orthogonality.
The DNA sequence to which T7 RNAP binds is
determined by a b-hairpin, known as the speciﬁcity loop,
which contacts the 12 to 7 bp region of the promoter
(36). Changes to the speciﬁcity loop confer the ability to
recognize different promoter sequences (37,38).
Remarkably, it had been shown that a single mutation
(N748D) switches T7 RNAP to preferentially bind a
T3-like phage promoter (39). Thus, this is a good region
to target mutagenesis; however, random mutations may be
disruptive and it could require too many simultaneous
mutations to generate orthogonality (40). Instead, we
took the approach of exchanging the entire b-hairpin
identiﬁed in RNAP from homologous phages. This is
related to previous work, where orthogonal transcription
factors were made by using information from a se-
quence database to guide mutations to the protein-DNA
interface (39).
Each phage in the T7 family contains an RNAP and
10–20 promoters that provide a wealth of information
about the interaction of the polymerase with DNA. To
identify b-hairpins that confer different binding
A
B C
Figure 2. Design of orthogonal T7 RNAPs and promoters. (A) Sequences of the speciﬁcity loop and promoter are shown for each orthogonal
polymerase. (B) The interaction between the T7 RNAP and T7 promoter is shown (36). The b-hairpin ‘speciﬁcity’ loop (red) interacts with the 50 end
of the promoter in the region marked ‘binding’. (C) The orthogonality between the engineered RNAP promoter pairs is shown. Each RNAP was
co-transformed individually with each promoter cloned into the base plasmid N155 (Supplementary Data) and expressed by 1 mM IPTG induction.
The data represent the average of three experiments performed on different days after subtraction of the autoﬂuorescence of Escherichia coli
harbouring no plasmid. The standard deviation of the experiments is reported in Supplementary Figure S4 and representative cytometry distributions
are shown in Supplementary Figure S7.
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speciﬁcities, we identiﬁed homologues of T7 RNAP and
computationally determined their DNA-binding prefer-
ences. First, 43 T7 RNAP homologues were identiﬁed
from NCBI via a protein–protein BLAST against non-
redundant protein sequences (25). RNAP with an
E-value less than 1100 and for which a fully sequenced
phage genome exists were selected for further analysis. A
multiple sequence alignment of the RNAP amino acid se-
quences was performed using ClustalW (26) to identify
and extract the b-hairpin in each RNAP corresponding
to T7 amino acids G732-P780. Three RNAPs (RSB2,
W5455 and fIBB-PF7A) were eliminated due to signiﬁ-
cant differences in length of the b-hairpins. A second
multiple sequence alignment was performed with only
the b-hairpin sequences, and 13 RNAP subfamilies were
identiﬁed (distance between members < 0.1 in the
ClustalW guide tree). Putative promoters were identiﬁed
from each phage genome using PHIRE, software that
scans genomes for regulatory elements by identifying
conserved sequences with a limited number of user-deﬁned
degeneracies (27). WebLogo was used to determine
the consensus sequence for each phage RNAP (41).
Remarkably, for each b-hairpin subfamily, the binding
region of the consensus promoter is identical (Sup-
plementary Figure S1).
Novel RNAPs were generated by swapping the
b-hairpin from T7 RNAP (Q744 to I761) with the equiva-
lent region from each subfamily (Figure 2B). The corres-
ponding binding region of the T7 promoter (12C to
7C) was replaced with the promoter subfamily consensus
sequences (Figure 2A). The resulting RNAPs were
screened for activity against their predicted promoters.
Four RNAPs exhibited strong activity (42-, 12-, 17-
and 40-fold induction by T7*, T7*(T3), T7*(K1F) and
T7*(N4), respectively) (Supplementary Figure S4) and
similar temporal induction (Supplementary Figure S6).
The activity of these RNAPs against non-cognate pro-
moters was then characterized. Each RNAP is highly
orthogonal, even after signiﬁcant mutations to both the
speciﬁcity loop and promoter (Figure 2C).
It is valuable to be able to tune the strength of a
promoter to achieve varied levels of transcription.
The T7 promoter has been shown to be modular, consist-
ing of a 6 bp RNAP-binding region and a 5 bp strength-
determining region (36,42,43). Mutations to the
strength-determining region should alter promoter
strength without affecting RNAP speciﬁcity (44,45). We
created a promoter library by randomizing the wild-type
T7 promoter from 2bp to +3bp. The library was
screened using ﬂow cytometry, and a set of representative
promoters was identiﬁed that includes a broad range of
expression levels spanning two orders of magnitude. These
promoters were sequenced to determine the mutations to
the strength-determining region (Figure 3A). These
regions were then combined with a different speciﬁcity-
determining region that is speciﬁc for T7*(T3). The rank
order for strength persists with fair correlation between
strengths of individual promoters (Figure 3B and
Supplementary Figure S5). Orthogonality is retained for
the hybrid promoters, where T7* only transcribes those
promoters containing the cognate-binding sequence and
vice versa for T7*(T3).
The set of orthogonal RNAPs enables the independent
control of multiple pathways by a genetic program
encoded on a controller. The modularity of the controller
allows it to be tested using ﬂuorescent reporters before
implementing it to control metabolic pathways or difﬁcult
to assay cellular functions. To demonstrate this, we con-
structed a simple genetic program whose output is two
RNAPs (T7* and T7*(K1F)) under the control of
multiple inducing signals and a logic gate (Figure 4).
T7* is expressed from the Ptac promoter by IPTG
A
B
Figure 3. Modularity of T7 promoters. (A) A library of pT7 promoters
of differing strengths was created by mutating the strength-determining
region (2bp to +3bp) and cloned into plasmid N155 (Supplementary
Data). Synonymous mutations were also made to the pT3 promoter.
Sequences are shown for the two libraries. (B) The promoter libraries
were used to control ﬂuorescent reporter proteins, and each library
was co-transformed with both T7* and T7*(T3). Activity of
co-transformants under 1mM IPTG induction was characterized by
ﬂow cytometry to study cognate interactions (T7*-PT7, top left and
T7*(T3)-PT3, bottom right) and non-cognate interactions (T7*-PT3,
bottom left and T7*(T3)-PT7, top right). Error bars represent the
standard deviation of three experiments on different days.
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induction (characterized in Supplementary Figure S3),
whereas T7*(K1F) is controlled by an AND gate that is
active only in the presence of both IPTG and anhydrote-
tracycline (aTc). The AND function is achieved by placing
a lacO-binding site after the transcription start site of the
Ptet promoter. Such promoter engineering has been
applied previously to build gates (46,47), and it is similar
to that used to build an edge detector program (11). We
characterized the performance of the genetic program
using reporter plasmids for each RNAP and veriﬁed that
it produced the expected circuit logic (Figure 4B). The
reporters are placed under the control of promoters re-
sponsive to each RNAP in the same genetic context as
the genes ultimately to be controlled. The T7* RNAP
exhibits 7.8-fold induction, whereas the T7*(K1F)
RNAP is induced 9.2-fold when tested using red ﬂuores-
cent protein and a low copy pSC101* origin.
Once the controller is veriﬁed, it can then be
co-transformed with the target pathways, which are
carried on a second plasmid. We applied the genetic
program to control the expression of two small molecule
pigments, lycopene (red) and deoxychromoviridans
(green). Escherichia coli produces small amounts of
lycopene through the 1-deoxy-D-xylulose-5-phosphate
(DXP) pathway following the introduction of the caroten-
oid genes crtEBI (Figure 5B) (48). Lycopene production
can be improved by overexpressing two genes, dxs and idi
(49,50). Deoxychromoviridans is synthesized from L-tryp-
tophan by the genes vioABE (51,52).
Each gene from both pathways was placed in a cistron
comprising an insulator, T7 or K1F promoter, synthetic
ribosome-binding site, the gene of interest and a T7 ter-
minator (Figure 5A). A library of T7-derived terminators
was created to avoid homologous recombination between
cistrons (Supplementary Data, Supplementary Figures S8
and S9). Synthetic cistrons were assembled into either a
lycopene operon or a deoxychromoviridans operon using
the Gibson assembly method (53). This method enabled us
to introduce a library of T7 promoters into each lycopene
cistron, co-transform the library with T7*, and screen for
efﬁcient producers under inducing conditions. We
identiﬁed and sequenced a clone that exhibited excellent
pigment production and contrast (T7 promoters indicated
in Figure 5A). For deoxychromoviridans, we obtained suf-
ﬁcient expression using wild-type promoters but found
that clones were not stable when vioE was expressed as a
cistron. Expressing vioB and vioE from a single K1F
promoter is stable and eliminates leaky expression of
deoxychromoviridans.
We then assessed the feasibility of connecting the
genetic program that was tuned and characterized in iso-
lation to the multigene pigment pathways. The genetic
program was co-transformed with the two biosynthetic
pathways, and cells were plated on varying inducer com-
binations (Figure 5C). Lycopene is synthesized in the
presence of IPTG and is not affected by the presence
of aTc. Deoxychromoviridans, in contrast, is only
synthesized when both inducing molecules are present.
Further quantiﬁcation was performed by extracting
pigments and measuring relative absorbance under the
different inducing states (50,54). We measured a 7.9-fold
induction of lycopene expression between the absence of
A
B
Figure 4. Design and characterization of a two-input genetic program. (A) A genetic program is shown that controls two orthogonal polymerases via
different logic. The activity of T7* was measured by co-transformation with a PT7 reporter plasmid (N489, Supplementary Data) with different
combinations of inducer (1mM IPTG and/or 10 ng/ml aTc). (B) K1F* activity was measured using a PK1F ﬂuorescent protein reporter (THSS40,
Supplementary Data, 1mM IPTG and/or 10 ng/ml aTc). Error bars represent the standard deviation of three experiments of different days.
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inducers and the addition of IPTG (Figure 5D). Lycopene
production in the presence of both IPTG and aTc yields a
5.6-fold induction, and induction of deoxychromoviridans
is 3.3-fold. The circuit performance obtained using the
ﬂuorescent reporters (Figure 4) closely matches with that
obtained using the more complex pathways (Figure 5D).
Genetic engineering is becoming increasingly complex,
requiring integrated control over multiple many-gene
pathways. Ultimately, it is envisioned that synthetic
systems could approach the size and complexity of
complete genomes. Our ability to engineer systems at
this scale is going to require modularization in their
design and testing. To this end, we present an approach
to decouple the genetic regulation controlling the
conditions and dynamics of gene expression from the
pathways that are being controlled. The sensors and
circuits can be constructed and tuned using ﬂuorescent
proteins, and the engineered pathways can be optimized
under simpliﬁed inducing conditions. Because the output
channels are orthogonal polymerases, the ‘controller’ can
switch from testing to implementation simply by
co-transforming it with the more complex pathways.
This has several advantages. First, the pathways may be
challenging to assay and inappropriate for the character-
ization of circuit dynamics. Second, this approach enables
the future development of highly integrated genetic
programs linking dozens of sensors and circuits that all
can be encoded in the controller. Thus, the modularization
Figure 5. Control of multiple pathways using a genetic controller and orthogonal polymerases. (A) The controller described from Fig. 4 is utilized to
control production of two pigments (lycopene and deoxychromoviridans). Operons are drawn using SBOLv symbols (55): RBSs (half circles),
insulators (crossed circles) and terminators (T). SynBERC Registry part numbers (registry.synberc.org) are shown for each part, and nucleotide
numbers for the plasmids are indicated. T7 promoter strength is reported as the ﬂuorescence of a RFP reporter from plasmid N155 (Supplementary
Data) and presented in relative expression units (REU, Supplementary Data, Supplementary Figure S2). (B) Biosynthetic pathways for lycopene and
deoxychromoviridans are shown. Intermediate products are shown in black, and genes expressed by the engineered system are shown in italics.
DMAPP, dimethylallyl diphosphate; DXP, 1-deoxy-D-xylulose 5-phosphate; FPP, farnesyl diphosphate; GGPP, geranylgeranyl pyrophosphate; G3P,
glyceraldehyde 3-phosphate; HMBPP, (E)-4-hydroxy-3-methylbut-2-enyl-diphosphate; IPA, indole-3-pyruvic acid; IPP, isopentenyl diphosphate.
(C) Pigment production follows the logic encoded by the controller. Escherichia coli strain MG1655 was co-transformed with plasmids encoding
the genetic program and both pathways. Cells were grown overnight in non-inducing conditions, diluted to an OD600 of 1.0, and spotted onto plates
containing inducers. In the presence of IPTG and aTc, both pigments are synthesized. The combination of green and red pigments appears brownish
purple. Photographs of representative colonies are shown. (D) Quantitative assessment of pigment production. Cells were grown for 24 h in LB media
containing the indicated inducers. Lycopene and deoxychromoviridans were extracted, and absorbance was measured (lycopene, 580 nm; deoxychro-
moviridans, 650 nm). Data are reported as the fraction of maximum absorbance observed. Error bars represent standard deviation of three experi-
ments of different days.
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of genetic programming enables it to be abstracted from
the idiosyncrasies of the biology being controlled.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Table 1, Supplementary Figures 1–10
and Supplementary References [56–63].
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